Opioid Prescriber Training Program Update | 1

Target Audience
Prescribers with a DEA number and medical residents prescribing under a facility DEA number.

Program Overview
The purpose of New York State (NYS) Prescription Drug Overdose (PDO) Prevention Program is to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse, and overdose. Effective July 22, 2016, Public Health Law Article 33 §3309-a was updated to require prescribers with a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number to complete a minimum of a 3-hours of course work or training in pain management, palliative care and addiction. Included in the PDO Prevention Program objectives, is an educational component for provider. The education outreach program will focus on updating providers on the Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain- United States, 2016 and the topics included in the educational mandate. This part 1 educational portion of the program will provide providers with 2.0 hours of CME (each) at no cost to the provider.

Accreditation Information
2.0 AMA PRA Category 1 Credit TM

Objectives

• Describe the pathophysiology and general approaches for pain management in the ambulatory setting.
• Describe approaches for managing acute pain and how they would differ from approaches for managing chronic pain.
• Outline clinical guidelines for appropriate prescribing of opioid analgesics.
• List the Federal and New York State requirements for prescribing controlled substances.

This Opioid Prescriber Training Program Part I covers four of the mandated topic areas:

• Pain management
• Appropriate prescribing
• Managing acute pain
• State and Federal requirements for prescribing controlled substances